Corcept Therapeutics Incorporated · NASDAQ:CORT

Mokari Atabak sold 40,000 Corcept Therapeutics Incorporated shares (Form 4)

Traded Jul 15, 2026 · Filed Jul 17, 2026

On Jul 15, 2026, Mokari Atabak (Chief Financial Officer) sold 40,000 Corcept Therapeutics Incorporated shares at an average US$87.71 for US$3.51M under a trading plan, leaving 16,130 shares. Filed Jul 17, 2026 (Form 4).

Sold
40,000 shares
Price
US$87.71 average (US$86.78 to US$89.43)
Value
US$3.51M
Holding after
16,130 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockOption exercise15,833US$19.2631,963Direct
Jul 15, 2026Common StockOption exercise24,167US$23.0656,130Direct
Jul 15, 2026Common StockSale7,919US$86.7848,211Direct
Jul 15, 2026Common StockSale28,460US$87.8919,751Direct
Jul 15, 2026Common StockSale3,520US$88.3016,231Direct
Jul 15, 2026Common StockSale101US$89.4316,130Direct

Source

View original at SEC

Related